Sort   by:  
 Page size 
We chose to perform a head-to-head immune-enrichment from primary liver tissue resections using both, MAGE-A4 and ESK1 TCR-like antibodies. Since both target antigens MAGE-A4 and WT-1 are not expressed in hepatocytes (Human Protein Atlas, www.proteinatlas.org), the ESK1 enrichment could serve as iso...
ORGANISM(S): Homo sapiens (Human) 
2024-03-30 | PXD048294 | Pride
To demonstrate the on-target binding of the MAGE-A4 antibody to the target HLAp GVYDGREHTV, we developed a reverse immunopeptidomics strategy that uses the HLAp-targeting antibody as a bait to enrich interacting HLAp from A375 xenografts. For this purpose, we immobilized the IgG-format of the MAGE-A...
ORGANISM(S): Homo sapiens (Human) 
2024-04-02 | PXD048298 | Pride
To demonstrate the on-target binding of the MAGE-A4 antibody to the target HLAp GVYDGREHTV, we developed a reverse immunopeptidomics strategy that uses the HLAp-targeting antibody as a bait to enrich interacting HLAp from A375 xenografts. For this purpose, we immobilized the IgG-format of the MAGE-A...
ORGANISM(S): Homo sapiens (Human) 
2024-03-30 | PXD048297 | Pride
We chose to perform immune-enrichment from primary lung and colon tissue resections using both, anti-MAGE-A4 in IgG format and control (anti-HLA-DQ, clone SPVL3) antibodies.
ORGANISM(S): Homo sapiens (Human) 
2024-03-30 | PXD048295 | Pride
Sort   by:  
 Page size